⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4579858 | 0.75 | — | — | |
| SCHEMBL21705192 | 0.72 | — | — | |
| SCHEMBL22593281 | 0.71 | — | — | |
| SCHEMBL8017389 | 0.69 | CNR1 (0.43) | — | |
| SCHEMBL21548455 | 0.67 | — | — | |
| SCHEMBL17244797 | 0.67 | — | — | |
| SCHEMBL1291910 | 0.64 | — | — | |
| SCHEMBL18765343 | 0.62 | — | — | |
| SCHEMBL23057906 | 0.62 | — | — | |
| SCHEMBL14966 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421761-B2 | Compounds for kinase modulation, and indications therefor | PLEXXIKON INC. (US) | 2019-09-24 | — | — | US | disclosed |
| US-20180099975-A1 | COMPOUNDS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC. | 2018-04-12 | — | — | US | disclosed |